Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Perspective Therapeutics (CATX) Return on Assets (2016 - 2025)

Historic Return on Assets for Perspective Therapeutics (CATX) over the last 14 years, with Q3 2025 value amounting to 0.0%.

  • Perspective Therapeutics' Return on Assets rose 200.0% to 0.0% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.0%, marking a year-over-year increase of 200.0%. This contributed to the annual value of 0.0% for FY2024, which is 1100.0% up from last year.
  • As of Q3 2025, Perspective Therapeutics' Return on Assets stood at 0.0%, which was up 200.0% from 0.0% recorded in Q2 2025.
  • Perspective Therapeutics' 5-year Return on Assets high stood at 0.0% for Q3 2025, and its period low was 0.16% during Q4 2022.
  • Over the past 5 years, Perspective Therapeutics' median Return on Assets value was 0.05% (recorded in 2021), while the average stood at 0.06%.
  • Per our database at Business Quant, Perspective Therapeutics' Return on Assets surged by 3800bps in 2021 and then tumbled by -1100bps in 2022.
  • Over the past 5 years, Perspective Therapeutics' Return on Assets (Quarter) stood at 0.05% in 2021, then tumbled by -239bps to 0.16% in 2022, then soared by 46bps to 0.09% in 2023, then surged by 97bps to 0.0% in 2024, then soared by 165bps to 0.0% in 2025.
  • Its Return on Assets stands at 0.0% for Q3 2025, versus 0.0% for Q2 2025 and 0.0% for Q1 2025.